New possible target for cancer treatment
Scientists at Karolinska Institutet in Sweden report that cancer cells and normal cells use different 'gene switches' in order to regulate the expression of genes...
Scientists at Karolinska Institutet in Sweden report that cancer cells and normal cells use different 'gene switches' in order to regulate the expression of genes...
Preliminary results of a new study show that sleep disturbance is strongly related to the use of alcohol, tobacco, and illicit drugs among student athletes...
Credit: University at Buffalo BUFFALO, N.Y. - Police officers on the afternoon shift are twice as likely to report being tired, according to a University...
Credit: JAMA Oncology PORTLAND, OR - People diagnosed with cancer gained 3.34 million years of life thanks to cancer clinical trials run by SWOG and...
Joseph M. Unger, Ph.D., M.S., of the SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Wash., and coauthors examined how the National...
Monday, June 5, 2017, Chicago, Ill.: After reviewing nearly 3.7 million patient records, Cleveland Clinic researchers have shown that newly diagnosed cancer patients are having...
The cancer risk for a human mission to Mars has effectively doubled following a UNLV study predicting a dramatic increase in the disease for astronauts...
CHICAGO - When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according...
COLUMBUS, Ohio - Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for...
PHILADELPHIA -- The American Association for Cancer Research (AACR) has published its first set of consensus screening recommendations for children with common cancer predisposition syndromes...
(Bethesda, MD, June 05, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported...
Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative...
CATONSVILLE, MD, June 5, 2017 - Offering comprehensive health insurance plans with low deductibles and co-pay in exchange for higher annual premiums seems like a...
ASCO Perspective "It's been nearly 15 years since EGFR-targeted therapies were introduced, helping extend survival for thousands of patients in the time since. The second...
ASCO Perspective "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission," said ASCO Expert...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.